We are live on
!
Find out more
AAM
Ardevora Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
26.09%
This Fund
S&P 500
This Quarter
Est. Return
+31.72%
1 Year Est. Return
+26.09%
3 Year Est. Return
+39.37%
5 Year Est. Return
+181.14%
10 Year Est. Return
–
AUM
$5.11B
AUM Growth
+$1.34B
(+35%)
Cap. Flow
+$307M
Cap. Flow
% of AUM
6.02%
Top 10 Holdings %
Top 10 Hldgs %
10.52%
Holding
129
New
22
Increased
39
Reduced
56
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$46.3M |
| 2 |
Cisco
CSCO
|
+$43.8M |
| 3 |
AutoZone
AZO
|
+$42.5M |
| 4 |
Linde
LIN
|
+$42.3M |
| 5 |
Henry Schein
HSIC
|
+$42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$64.5M |
| 2 |
Dollar General
DG
|
+$57.3M |
| 3 |
MSCI
MSCI
|
+$55.2M |
| 4 |
Atlassian
TEAM
|
+$48.7M |
| 5 |
Repligen
RGEN
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.39% |
| 2 | Healthcare | 16.19% |
| 3 | Industrials | 14.76% |
| 4 | Consumer Discretionary | 13.07% |
| 5 | Communication Services | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nasdaq
NDAQ
$53.8B
| $48.4M | 0.95% |
1,214,136
-190,242
| -14% | -$7.08M |
|
|
LVGO
27
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $48.3M | 0.94% |
+641,759
| New | +$33.6M |
|
28
Fortive
FTV
$18B
| $48.2M | 0.94% |
1,129,188
-21,572
| -2% | -$842K |
|
29
Humana
HUM
$43.3B
| $48M | 0.94% |
123,757
-26,513
| -18% | -$9.92M |
|
30
Visa
V
$704B
| $48M | 0.94% |
248,378
-8,990
| -3% | -$1.64M |
|
31
ResMed
RMD
$30.9B
| $47.8M | 0.94% |
249,193
+248,493
| +35,499% | +$40.7M |
|
32
Zoetis
ZTS
$32.7B
| $47.8M | 0.94% |
348,897
-19,003
| -5% | -$2.48M |
|
33
Home Depot
HD
$341B
| $47.6M | 0.93% |
190,047
+7,376
| +4% | +$1.69M |
|
34
Fair Isaac
FICO
$32.3B
| $47.6M | 0.93% |
113,814
-26,949
| -19% | -$9.84M |
|
35
Alphabet (Google) Class A
GOOGL
$4.11T
| $47.5M | 0.93% |
670,440
+95,580
| +17% | +$6.44M |
|
36
American Water Works
AWK
$26.9B
| $47.5M | 0.93% |
369,333
-20,172
| -5% | -$2.51M |
|
37
Baxter International
BAX
$12.7B
| $47.5M | 0.93% |
551,436
+88,840
| +19% | +$7.74M |
|
38
Meta Platforms (Facebook)
META
$1.5T
| $47.4M | 0.93% |
208,842
-2,358
| -1% | -$492K |
|
|
39
Bio-Rad Laboratories Class A
BIO
$8.73B
| $47.3M | 0.93% |
+104,857
| New | +$46.3M |
|
|
NAV
40
DELISTED
Navistar International
NAV
| $47.3M | 0.93% |
1,678,140
+231,153
| +16% | +$5.48M |
|
41
Procter & Gamble
PG
$338B
| $47.1M | 0.92% |
393,779
-21
| -0% | -$2.45K |
|
42
Rockwell Automation
ROK
$50.7B
| $47.1M | 0.92% |
220,966
-51,234
| -19% | -$9.91M |
|
43
Mettler-Toledo International
MTD
$28.1B
| $47.1M | 0.92% |
58,426
-6,905
| -11% | -$5.14M |
|
44
Atmos Energy
ATO
$29.9B
| $46.9M | 0.92% |
471,017
+11,817
| +3% | +$1.19M |
|
45
Mondelez International
MDLZ
$83.9B
| $46.9M | 0.92% |
916,586
+65,086
| +8% | +$3.34M |
|
46
Roper Technologies
ROP
$40.4B
| $46.7M | 0.91% |
120,383
-13,715
| -10% | -$4.91M |
|
47
Waste Management
WM
$95.6B
| $46.7M | 0.91% |
441,221
+26,421
| +6% | +$2.67M |
|
48
Mastercard
MA
$500B
| $46.6M | 0.91% |
157,713
+25,755
| +20% | +$7.26M |
|
49
Ambev
ABEV
$47.9B
| $46.6M | 0.91% |
17,652,402
+2,806,742
| +19% | +$6.62M |
|
|
50
Cisco
CSCO
$451B
| $46.6M | 0.91% |
+998,584
| New | +$43.8M |
|
Similar funds
TC
B
DI
DGAM
FAAM
SFG
BWM
SGCIA
Ardevora Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Ardevora Asset Management held 129 positions worth $5.11B, up 35% from $3.77B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Ardevora Asset Management deployed $307M of net new capital in Q2 2020, opening 22 new positions and adding to 39 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 104,857 shares worth $47.3M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was DexCom, an estimated $64.5M trimmed.
- Ardevora Asset Management's largest Q2 2020 buy was Bio-Rad Laboratories Class A: 104,857 shares worth $47.3M.
- Ardevora Asset Management added most to ResMed in Q2 2020, an estimated $40.7M increase.
- Ardevora Asset Management's biggest Q2 2020 reduction was DexCom, cutting an estimated $64.5M.
- Ardevora Asset Management fully exited Atlassian in Q2 2020, selling an estimated $48.7M.
- Ardevora Asset Management's ten largest holdings make up 11% of its $5.11B portfolio in Q2 2020.
- Ardevora Asset Management opened 22 new positions and closed 12 in Q2 2020.
- Ardevora Asset Management's portfolio value rose 35% quarter-over-quarter to $5.11B.
Based on Ardevora Asset Management's 13F filing for Q2 2020, filed 28 Jul 2020.